flexyn2a
Vaccineexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2015 (NCT02388009)
Timeline
Indications
Studied for
Mechanism of action
- ShigellaImmunity, active
Shigella immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- flexyn2a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02646371 | Phase 2 | Dec 1, 2015 | Johns Hopkins University, LimmaTech Biologics AG |
| NCT02388009 | Phase 1 | Feb 1, 2015 | LimmaTech Biologics AG, United States Navy, Wellcome Trust |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| LimmaTech Biologics AG | For profit | 2 | 2 | 2 | 2015 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| United States Navy | Government | 1 | 0 | 1 | 2015 |
| Wellcome Trust | Academic/Hospital | 1 | 0 | 1 | 2015 |
4 organizations
Page 1 / 1